- Home
- UNCY vs BMN Comparison
UNCY vs BMN Comparison
Compare UNCY & BMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | UNCY | BMN |
|---|---|---|
| Founded | 2016 | N/A |
| Country | United States | United States |
| Employees | 22 | 19800 |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 138.3M | 155.2M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | UNCY | BMN |
|---|---|---|
| Price | $5.07 | $25.33 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $25.67 | N/A |
| AVG Volume (30 Days) | ★ 832.9K | 6.1K |
| Earning Date | 05-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $675,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $582.86 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.72 | $24.00 |
| 52 Week High | $8.74 | $27.96 |
Technical Indicators
Market Signals| Indicator | UNCY | BMN |
|---|---|---|
| Relative Strength Index (RSI) | 42.46 | 45.31 |
| Support Level | $4.81 | $24.55 |
| Resistance Level | $5.39 | $25.30 |
| Average True Range (ATR) | 0.31 | 0.32 |
| MACD | 0.06 | 0.00 |
| Stochastic Oscillator | 29.31 | 39.77 |
Price Performance
Historical ComparisonAbout UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease. The company is advancing two key product candidates: oxylanthanum carbonate (OLC), a phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis, and UNI-494, a drug candidate for the treatment of acute kidney injury.
About BMN BlackRock 2037 Municipal Target Term Trust of Beneficial Interest
BlackRock 2037 Mun Tgt is a non-diversified, closed-end management investment company. The Trust's investment objective is to provide current income that is exempt from regular federal income tax. The Trust invests in investment grade quality securities or securities that are unrated but judged to be of comparable quality by the investment adviser.